Company intelligence / Profile preview

Salomon

Jerusalem, Israel

Ownership: Private
Development stage: Other

Overview

Founded as a pharmaceutical distributor and retail operation in Jerusalem in 1901, Salomon Levin Elstein merged into Teva, which is now one of the world's largest generic pharmaceutical manufacturers. SLE's legacy is as a foundational entity in Israel's pharmaceutical industry, now subsumed into Teva's global product portfolio.

Modalities: Small moleculeMonoclonal antibodyBiologic
Industry: Pharma

Partnerships

MODAG

Beyond the preview

Go deeper on Salomon.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Salomon.

Explore the full profile